Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

24 Jul 2017 07:00

RNS Number : 8093L
Biome Technologies PLC
24 July 2017
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

24 July 2017

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update for the six months ended 30 June 2017. The unaudited interim results are expected to be announced on 4 September 2017.

 

Total Group revenues for the first half of the year were £3.0m, representing a 38% increase compared to the same period last year (2016: £2.2m).

 

The Directors expect that the Group will report a small profit before interest, tax, depreciation, amortisation, and share option charges for the first half of the year (based on unaudited management accounts).

 

The Group's cash position as at 30 June 2017 was £1.9m (31 December 2016: £1.5m, 31 March 2017 £1.8m), reflecting trading activity and receipt of £0.45m in Q1 under the settlement agreement reported previously.

 

 

Bioplastics Division

Revenues in the Bioplastics division in H1 2017 were £1.2m, 114% ahead of last year (H1 2016: £0.6m). This growth is a result of both good demand for commercialised products from the US single-serve coffee market and growth of revenues from the Company's biodegradable non-woven filter for coffee pods. Lower sales in Q2 versus Q1 are reflective of timings of production runs by customers for outer packaging over the period.

 

The non-woven filter developed over the past three years continues to move towards full commercialisation and pods incorporating this material are now being utilised within a first customer's range. These are being marketed as 100% compostable pods in the consumer market. Further growth from this initial customer is expected as the full product range is converted from oil based to bioplastic materials over the coming months. The Group looks forward to further progress within the Bioplastics division during the second half of the year.

 

 

Stanelco RF Technologies Division

Revenues for H1 2017 in the RF Technologies division were up 10% to £1.7m (H1 2016: £1.6m). Good revenue levels in the period were supported by the build and delivery of several fibre optic furnaces. A solid order book and good enquiry pipeline underpin a very strong outlook for this division for the second half and into 2018.

 

 

Outlook

Biome continues to make progress against the strategy as set out in the Group's full year results announced in March 2017 and against this background the Board remains confident in the Group's outlook for the remainder of the year.

 

- Ends -

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Richard Short (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKDDKABKDPOB
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.